STAT5B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.205250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.796800E-01
Normal-vs-Stage2
7.056100E-02
Normal-vs-Stage3
2.613000E-01
Normal-vs-Stage4
5.201800E-01
Stage1-vs-Stage2
8.233800E-02
Stage1-vs-Stage3
1.295590E-01
Stage1-vs-Stage4
6.755600E-01
Stage2-vs-Stage3
2.255400E-01
Stage2-vs-Stage4
4.568000E-01
Stage3-vs-Stage4
8.017700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.320030E-01
Normal-vs-AfricanAmerican
4.131000E-01
Normal-vs-Asian
4.957800E-02
Caucasian-vs-AfricanAmerican
7.267200E-01
Caucasian-vs-Asian
7.311700E-02
AfricanAmerican-vs-Asian
1.333200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.164580E-01
Normal-vs-Female
1.519790E-01
Male-vs-Female
5.567600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.638600E-01
Normal-vs-Age(41-60Yrs)
2.219600E-01
Normal-vs-Age(61-80Yrs)
1.050750E-01
Normal-vs-Age(81-100Yrs)
3.353800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.641000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.275750E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.298000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.025900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.496100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.360000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.683500E-02
Normal-vs-Daily Drinker
5.478100E-02
Normal-vs-Weekly Drinker
9.664300E-02
Normal-vs-Occasional Drinker
1.991950E-01
Normal-vs-Social Drinker
4.680800E-01
Non Drinker-vs-Daily Drinker
9.653000E-01
Non Drinker-vs-Weekly Drinker
7.328400E-01
Non Drinker-vs-Occasional Drinker
1.608620E-01
Non Drinker-vs-Social Drinker
9.232500E-02
Daily Drinker-vs-Weekly Drinker
7.581600E-01
Daily Drinker-vs-Occasional Drinker
1.755030E-01
Daily Drinker-vs-Social Drinker
1.122000E-01
Weekly Drinker-vs-Occasional Drinker
3.463000E-01
Weekly Drinker-vs-Social Drinker
2.414400E-01
Occasional Drinker-vs-Social Drinker
6.123400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.269990E-01
Normal-vs-Grade 2
3.974300E-02
Normal-vs-Grade 3
2.281900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.782830E-01
Grade 1-vs-Grade 3
6.971500E-02
Grade 1-vs-Grade 4
1.269990E-01
Grade 2-vs-Grade 3
3.183200E-01
Grade 2-vs-Grade 4
3.974300E-02
Grade 3-vs-Grade 4
2.281900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.387030E-01
Normal-vs-NonDiabetic
9.107700E-02
Diabetic-vs-NonDiabetic
8.796400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.326010E-01
Normal-vs-NoPancreatitis
1.028400E-01
Pancreatitis-vs-NoPancreatitis
5.579800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.283200E-01
Normal-vs-N1
6.934400E-02
N0-vs-N1
4.987800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.110000E-01
Normal-vs-TP53-NonMutant
3.367600E-01
TP53-Mutant-vs-TP53-NonMutant
2.173200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
